nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CLCN2—endothelium—malaria	0.134	0.405	CbGeAlD
Lubiprostone—CLCN2—blood—malaria	0.0437	0.132	CbGeAlD
Lubiprostone—CBR1—saliva-secreting gland—malaria	0.0277	0.0835	CbGeAlD
Lubiprostone—CLCN2—brain—malaria	0.0271	0.0817	CbGeAlD
Lubiprostone—CBR1—kidney—malaria	0.0217	0.0653	CbGeAlD
Lubiprostone—Dinoprostone—HPGDS—malaria	0.0206	1	CrCbGaD
Lubiprostone—CBR1—digestive system—malaria	0.0184	0.0554	CbGeAlD
Lubiprostone—CBR1—blood—malaria	0.0175	0.0528	CbGeAlD
Lubiprostone—CBR1—bone marrow—malaria	0.0169	0.0511	CbGeAlD
Lubiprostone—CBR1—liver—malaria	0.0137	0.0413	CbGeAlD
Lubiprostone—CBR1—brain—malaria	0.0109	0.0327	CbGeAlD
Lubiprostone—Mediastinal disorder—Proguanil—malaria	0.00734	0.0115	CcSEcCtD
Lubiprostone—Mental disorder—Proguanil—malaria	0.00714	0.0112	CcSEcCtD
Lubiprostone—Erythema—Proguanil—malaria	0.00709	0.0111	CcSEcCtD
Lubiprostone—Malnutrition—Proguanil—malaria	0.00709	0.0111	CcSEcCtD
Lubiprostone—Anorexia—Pyrimethamine—malaria	0.00708	0.0111	CcSEcCtD
Lubiprostone—Eructation—Pentoxifylline—malaria	0.00696	0.0109	CcSEcCtD
Lubiprostone—Swelling—Clindamycin—malaria	0.0066	0.0103	CcSEcCtD
Lubiprostone—Decreased appetite—Pyrimethamine—malaria	0.00646	0.0101	CcSEcCtD
Lubiprostone—Cough—Proguanil—malaria	0.00619	0.00969	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.006	0.00939	CcSEcCtD
Lubiprostone—Swelling—Pentoxifylline—malaria	0.00583	0.00913	CcSEcCtD
Lubiprostone—Nervous system disorder—Proguanil—malaria	0.00568	0.00889	CcSEcCtD
Lubiprostone—Skin disorder—Proguanil—malaria	0.00562	0.0088	CcSEcCtD
Lubiprostone—Anorexia—Proguanil—malaria	0.00552	0.00864	CcSEcCtD
Lubiprostone—Hypersensitivity—Pyrimethamine—malaria	0.00547	0.00857	CcSEcCtD
Lubiprostone—Lethargy—Quinidine barbiturate—malaria	0.00526	0.00824	CcSEcCtD
Lubiprostone—Cramp muscle—Clindamycin—malaria	0.00524	0.00821	CcSEcCtD
Lubiprostone—Influenza—Dapsone—malaria	0.0052	0.00814	CcSEcCtD
Lubiprostone—Abdominal distension—Clindamycin—malaria	0.00507	0.00793	CcSEcCtD
Lubiprostone—Decreased appetite—Proguanil—malaria	0.00503	0.00788	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Proguanil—malaria	0.005	0.00782	CcSEcCtD
Lubiprostone—Abdominal discomfort—Clindamycin—malaria	0.00482	0.00755	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Proguanil—malaria	0.00473	0.00741	CcSEcCtD
Lubiprostone—Vomiting—Pyrimethamine—malaria	0.00472	0.0074	CcSEcCtD
Lubiprostone—Abdominal pain—Proguanil—malaria	0.00458	0.00716	CcSEcCtD
Lubiprostone—Abdominal distension—Pentoxifylline—malaria	0.00448	0.00701	CcSEcCtD
Lubiprostone—Urinary tract infection—Clindamycin—malaria	0.00436	0.00683	CcSEcCtD
Lubiprostone—Abdominal discomfort—Pentoxifylline—malaria	0.00426	0.00667	CcSEcCtD
Lubiprostone—Diarrhoea—Proguanil—malaria	0.00396	0.0062	CcSEcCtD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.00378	0.43	CbGpPWpGaD
Lubiprostone—Vomiting—Proguanil—malaria	0.00368	0.00576	CcSEcCtD
Lubiprostone—Anorexia—Sulfadiazine—malaria	0.00366	0.00573	CcSEcCtD
Lubiprostone—Rash—Proguanil—malaria	0.00365	0.00571	CcSEcCtD
Lubiprostone—Dermatitis—Proguanil—malaria	0.00365	0.00571	CcSEcCtD
Lubiprostone—Headache—Proguanil—malaria	0.00363	0.00568	CcSEcCtD
Lubiprostone—Erythema—Dapsone—malaria	0.00362	0.00567	CcSEcCtD
Lubiprostone—Mediastinal disorder—Quinine—malaria	0.00356	0.00558	CcSEcCtD
Lubiprostone—Mediastinal disorder—Quinidine—malaria	0.00356	0.00558	CcSEcCtD
Lubiprostone—Erythema—Clindamycin—malaria	0.00351	0.00549	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Sulfadiazine—malaria	0.0035	0.00548	CcSEcCtD
Lubiprostone—Mental disorder—Quinidine—malaria	0.00346	0.00542	CcSEcCtD
Lubiprostone—Mental disorder—Quinine—malaria	0.00346	0.00542	CcSEcCtD
Lubiprostone—Flatulence—Clindamycin—malaria	0.00346	0.00541	CcSEcCtD
Lubiprostone—Malnutrition—Quinine—malaria	0.00344	0.00539	CcSEcCtD
Lubiprostone—Erythema—Quinidine—malaria	0.00344	0.00539	CcSEcCtD
Lubiprostone—Erythema—Quinine—malaria	0.00344	0.00539	CcSEcCtD
Lubiprostone—Malnutrition—Quinidine—malaria	0.00344	0.00539	CcSEcCtD
Lubiprostone—Nausea—Proguanil—malaria	0.00344	0.00538	CcSEcCtD
Lubiprostone—Dysgeusia—Clindamycin—malaria	0.00343	0.00538	CcSEcCtD
Lubiprostone—Muscle spasms—Clindamycin—malaria	0.00337	0.00528	CcSEcCtD
Lubiprostone—Decreased appetite—Sulfadiazine—malaria	0.00334	0.00523	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Sulfadiazine—malaria	0.00332	0.00519	CcSEcCtD
Lubiprostone—Tremor—Quinine—malaria	0.00322	0.00505	CcSEcCtD
Lubiprostone—Tremor—Quinidine—malaria	0.00322	0.00505	CcSEcCtD
Lubiprostone—Mediastinal disorder—Quinidine barbiturate—malaria	0.00321	0.00503	CcSEcCtD
Lubiprostone—Cough—Dapsone—malaria	0.00316	0.00495	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Sulfadiazine—malaria	0.00314	0.00492	CcSEcCtD
Lubiprostone—Mental disorder—Quinidine barbiturate—malaria	0.00312	0.00489	CcSEcCtD
Lubiprostone—Malnutrition—Quinidine barbiturate—malaria	0.0031	0.00486	CcSEcCtD
Lubiprostone—Erythema—Quinidine barbiturate—malaria	0.0031	0.00486	CcSEcCtD
Lubiprostone—Erythema—Pentoxifylline—malaria	0.0031	0.00485	CcSEcCtD
Lubiprostone—Syncope—Quinidine—malaria	0.00308	0.00483	CcSEcCtD
Lubiprostone—Syncope—Quinine—malaria	0.00308	0.00483	CcSEcCtD
Lubiprostone—Flatulence—Pentoxifylline—malaria	0.00305	0.00478	CcSEcCtD
Lubiprostone—Palpitations—Quinidine—malaria	0.00304	0.00476	CcSEcCtD
Lubiprostone—Palpitations—Quinine—malaria	0.00304	0.00476	CcSEcCtD
Lubiprostone—Abdominal pain—Sulfadiazine—malaria	0.00304	0.00476	CcSEcCtD
Lubiprostone—Dysgeusia—Pentoxifylline—malaria	0.00303	0.00475	CcSEcCtD
Lubiprostone—Loss of consciousness—Quinidine—malaria	0.00302	0.00473	CcSEcCtD
Lubiprostone—Loss of consciousness—Quinine—malaria	0.00302	0.00473	CcSEcCtD
Lubiprostone—Muscle spasms—Pentoxifylline—malaria	0.00298	0.00466	CcSEcCtD
Lubiprostone—Discomfort—Clindamycin—malaria	0.00295	0.00462	CcSEcCtD
Lubiprostone—Myalgia—Quinidine—malaria	0.00293	0.00458	CcSEcCtD
Lubiprostone—Chest pain—Quinidine—malaria	0.00293	0.00458	CcSEcCtD
Lubiprostone—Chest pain—Quinine—malaria	0.00293	0.00458	CcSEcCtD
Lubiprostone—Myalgia—Quinine—malaria	0.00293	0.00458	CcSEcCtD
Lubiprostone—Tremor—Quinidine barbiturate—malaria	0.00291	0.00455	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00291	0.00455	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00291	0.00455	CcSEcCtD
Lubiprostone—Tremor—Pentoxifylline—malaria	0.0029	0.00455	CcSEcCtD
Lubiprostone—Tachycardia—Dapsone—malaria	0.00289	0.00452	CcSEcCtD
Lubiprostone—Ill-defined disorder—Pentoxifylline—malaria	0.00288	0.0045	CcSEcCtD
Lubiprostone—Hypersensitivity—Sulfadiazine—malaria	0.00283	0.00443	CcSEcCtD
Lubiprostone—Oedema—Quinine—malaria	0.00281	0.00439	CcSEcCtD
Lubiprostone—Oedema—Quinidine—malaria	0.00281	0.00439	CcSEcCtD
Lubiprostone—Malaise—Pentoxifylline—malaria	0.00279	0.00437	CcSEcCtD
Lubiprostone—Syncope—Quinidine barbiturate—malaria	0.00278	0.00436	CcSEcCtD
Lubiprostone—Shock—Quinidine—malaria	0.00276	0.00432	CcSEcCtD
Lubiprostone—Shock—Quinine—malaria	0.00276	0.00432	CcSEcCtD
Lubiprostone—Nervous system disorder—Quinidine—malaria	0.00275	0.00431	CcSEcCtD
Lubiprostone—Nervous system disorder—Quinine—malaria	0.00275	0.00431	CcSEcCtD
Lubiprostone—Palpitations—Quinidine barbiturate—malaria	0.00274	0.00429	CcSEcCtD
Lubiprostone—Tachycardia—Quinine—malaria	0.00274	0.00429	CcSEcCtD
Lubiprostone—Tachycardia—Quinidine—malaria	0.00274	0.00429	CcSEcCtD
Lubiprostone—Palpitations—Pentoxifylline—malaria	0.00274	0.00429	CcSEcCtD
Lubiprostone—Loss of consciousness—Quinidine barbiturate—malaria	0.00273	0.00427	CcSEcCtD
Lubiprostone—Skin disorder—Quinidine—malaria	0.00273	0.00427	CcSEcCtD
Lubiprostone—Skin disorder—Quinine—malaria	0.00273	0.00427	CcSEcCtD
Lubiprostone—Hyperhidrosis—Quinidine—malaria	0.00271	0.00425	CcSEcCtD
Lubiprostone—Hyperhidrosis—Quinine—malaria	0.00271	0.00425	CcSEcCtD
Lubiprostone—Anorexia—Quinidine—malaria	0.00268	0.00419	CcSEcCtD
Lubiprostone—Anorexia—Quinine—malaria	0.00268	0.00419	CcSEcCtD
Lubiprostone—Chest pain—Quinidine barbiturate—malaria	0.00264	0.00414	CcSEcCtD
Lubiprostone—Myalgia—Quinidine barbiturate—malaria	0.00264	0.00414	CcSEcCtD
Lubiprostone—Myalgia—Pentoxifylline—malaria	0.00264	0.00413	CcSEcCtD
Lubiprostone—Chest pain—Pentoxifylline—malaria	0.00264	0.00413	CcSEcCtD
Lubiprostone—Anxiety—Quinidine barbiturate—malaria	0.00263	0.00412	CcSEcCtD
Lubiprostone—Diarrhoea—Sulfadiazine—malaria	0.00263	0.00412	CcSEcCtD
Lubiprostone—Anxiety—Pentoxifylline—malaria	0.00263	0.00412	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.00262	0.00411	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00262	0.0041	CcSEcCtD
Lubiprostone—Discomfort—Pentoxifylline—malaria	0.00261	0.00408	CcSEcCtD
Lubiprostone—Dry mouth—Pentoxifylline—malaria	0.00258	0.00404	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Quinine—malaria	0.00256	0.004	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Quinidine—malaria	0.00256	0.004	CcSEcCtD
Lubiprostone—Dyspnoea—Clindamycin—malaria	0.00255	0.00399	CcSEcCtD
Lubiprostone—Oedema—Quinidine barbiturate—malaria	0.00253	0.00397	CcSEcCtD
Lubiprostone—Oedema—Pentoxifylline—malaria	0.00253	0.00396	CcSEcCtD
Lubiprostone—Dyspepsia—Clindamycin—malaria	0.00252	0.00394	CcSEcCtD
Lubiprostone—Dyspnoea—Quinine—malaria	0.0025	0.00392	CcSEcCtD
Lubiprostone—Dyspnoea—Quinidine—malaria	0.0025	0.00392	CcSEcCtD
Lubiprostone—Shock—Quinidine barbiturate—malaria	0.00249	0.0039	CcSEcCtD
Lubiprostone—Shock—Pentoxifylline—malaria	0.00249	0.0039	CcSEcCtD
Lubiprostone—Nervous system disorder—Quinidine barbiturate—malaria	0.00248	0.00389	CcSEcCtD
Lubiprostone—Tachycardia—Quinidine barbiturate—malaria	0.00247	0.00387	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Clindamycin—malaria	0.00247	0.00387	CcSEcCtD
Lubiprostone—Tachycardia—Pentoxifylline—malaria	0.00247	0.00386	CcSEcCtD
Lubiprostone—Fatigue—Clindamycin—malaria	0.00247	0.00386	CcSEcCtD
Lubiprostone—Skin disorder—Quinidine barbiturate—malaria	0.00246	0.00385	CcSEcCtD
Lubiprostone—Skin disorder—Pentoxifylline—malaria	0.00246	0.00385	CcSEcCtD
Lubiprostone—Hyperhidrosis—Quinidine barbiturate—malaria	0.00245	0.00383	CcSEcCtD
Lubiprostone—Pain—Clindamycin—malaria	0.00245	0.00383	CcSEcCtD
Lubiprostone—Constipation—Clindamycin—malaria	0.00245	0.00383	CcSEcCtD
Lubiprostone—Hyperhidrosis—Pentoxifylline—malaria	0.00244	0.00383	CcSEcCtD
Lubiprostone—Vomiting—Sulfadiazine—malaria	0.00244	0.00383	CcSEcCtD
Lubiprostone—Decreased appetite—Quinine—malaria	0.00244	0.00382	CcSEcCtD
Lubiprostone—Decreased appetite—Quinidine—malaria	0.00244	0.00382	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Quinidine—malaria	0.00242	0.00379	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Quinine—malaria	0.00242	0.00379	CcSEcCtD
Lubiprostone—Rash—Sulfadiazine—malaria	0.00242	0.00379	CcSEcCtD
Lubiprostone—Dermatitis—Sulfadiazine—malaria	0.00242	0.00379	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Dapsone—malaria	0.00242	0.00379	CcSEcCtD
Lubiprostone—Anorexia—Quinidine barbiturate—malaria	0.00242	0.00378	CcSEcCtD
Lubiprostone—Anorexia—Pentoxifylline—malaria	0.00241	0.00377	CcSEcCtD
Lubiprostone—Headache—Sulfadiazine—malaria	0.00241	0.00377	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Clindamycin—malaria	0.00234	0.00366	CcSEcCtD
Lubiprostone—Abdominal pain—Dapsone—malaria	0.00234	0.00366	CcSEcCtD
Lubiprostone—Feeling abnormal—Quinidine—malaria	0.00231	0.00362	CcSEcCtD
Lubiprostone—Feeling abnormal—Quinine—malaria	0.00231	0.00362	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.00231	0.00361	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Pentoxifylline—malaria	0.0023	0.00361	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Quinidine—malaria	0.0023	0.00359	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Quinine—malaria	0.0023	0.00359	CcSEcCtD
Lubiprostone—Nausea—Sulfadiazine—malaria	0.00228	0.00357	CcSEcCtD
Lubiprostone—Abdominal pain—Clindamycin—malaria	0.00226	0.00354	CcSEcCtD
Lubiprostone—Dyspnoea—Quinidine barbiturate—malaria	0.00226	0.00354	CcSEcCtD
Lubiprostone—Dyspnoea—Pentoxifylline—malaria	0.00225	0.00353	CcSEcCtD
Lubiprostone—Dyspepsia—Pentoxifylline—malaria	0.00223	0.00349	CcSEcCtD
Lubiprostone—Abdominal pain—Quinidine—malaria	0.00222	0.00347	CcSEcCtD
Lubiprostone—Abdominal pain—Quinine—malaria	0.00222	0.00347	CcSEcCtD
Lubiprostone—Decreased appetite—Quinidine barbiturate—malaria	0.0022	0.00345	CcSEcCtD
Lubiprostone—Decreased appetite—Pentoxifylline—malaria	0.0022	0.00344	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.00219	0.00342	CcSEcCtD
Lubiprostone—Pain—Quinidine barbiturate—malaria	0.00217	0.00339	CcSEcCtD
Lubiprostone—Constipation—Quinidine barbiturate—malaria	0.00217	0.00339	CcSEcCtD
Lubiprostone—Constipation—Pentoxifylline—malaria	0.00216	0.00339	CcSEcCtD
Lubiprostone—Hypersensitivity—Clindamycin—malaria	0.00211	0.0033	CcSEcCtD
Lubiprostone—Feeling abnormal—Quinidine barbiturate—malaria	0.00209	0.00327	CcSEcCtD
Lubiprostone—Feeling abnormal—Pentoxifylline—malaria	0.00208	0.00326	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Quinidine barbiturate—malaria	0.00207	0.00324	CcSEcCtD
Lubiprostone—Hypersensitivity—Quinidine—malaria	0.00207	0.00324	CcSEcCtD
Lubiprostone—Hypersensitivity—Quinine—malaria	0.00207	0.00324	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Pentoxifylline—malaria	0.00207	0.00324	CcSEcCtD
Lubiprostone—Asthenia—Clindamycin—malaria	0.00205	0.00321	CcSEcCtD
Lubiprostone—Asthenia—Quinine—malaria	0.00201	0.00315	CcSEcCtD
Lubiprostone—Asthenia—Quinidine—malaria	0.00201	0.00315	CcSEcCtD
Lubiprostone—Abdominal pain—Quinidine barbiturate—malaria	0.002	0.00314	CcSEcCtD
Lubiprostone—Abdominal pain—Pentoxifylline—malaria	0.002	0.00313	CcSEcCtD
Lubiprostone—Diarrhoea—Clindamycin—malaria	0.00196	0.00307	CcSEcCtD
Lubiprostone—Diarrhoea—Quinine—malaria	0.00192	0.00301	CcSEcCtD
Lubiprostone—Diarrhoea—Quinidine—malaria	0.00192	0.00301	CcSEcCtD
Lubiprostone—Dizziness—Clindamycin—malaria	0.00189	0.00296	CcSEcCtD
Lubiprostone—Vomiting—Dapsone—malaria	0.00188	0.00294	CcSEcCtD
Lubiprostone—Hypersensitivity—Quinidine barbiturate—malaria	0.00187	0.00292	CcSEcCtD
Lubiprostone—Hypersensitivity—Pentoxifylline—malaria	0.00186	0.00292	CcSEcCtD
Lubiprostone—Dizziness—Quinidine—malaria	0.00186	0.00291	CcSEcCtD
Lubiprostone—Dizziness—Quinine—malaria	0.00186	0.00291	CcSEcCtD
Lubiprostone—Headache—Dapsone—malaria	0.00185	0.0029	CcSEcCtD
Lubiprostone—Vomiting—Clindamycin—malaria	0.00182	0.00285	CcSEcCtD
Lubiprostone—Asthenia—Quinidine barbiturate—malaria	0.00182	0.00285	CcSEcCtD
Lubiprostone—Asthenia—Pentoxifylline—malaria	0.00181	0.00284	CcSEcCtD
Lubiprostone—Rash—Clindamycin—malaria	0.0018	0.00282	CcSEcCtD
Lubiprostone—Dermatitis—Clindamycin—malaria	0.0018	0.00282	CcSEcCtD
Lubiprostone—Headache—Clindamycin—malaria	0.00179	0.00281	CcSEcCtD
Lubiprostone—Vomiting—Quinidine—malaria	0.00178	0.00279	CcSEcCtD
Lubiprostone—Vomiting—Quinine—malaria	0.00178	0.00279	CcSEcCtD
Lubiprostone—Rash—Quinidine—malaria	0.00177	0.00277	CcSEcCtD
Lubiprostone—Rash—Quinine—malaria	0.00177	0.00277	CcSEcCtD
Lubiprostone—Dermatitis—Quinidine—malaria	0.00177	0.00277	CcSEcCtD
Lubiprostone—Dermatitis—Quinine—malaria	0.00177	0.00277	CcSEcCtD
Lubiprostone—Headache—Quinidine—malaria	0.00176	0.00275	CcSEcCtD
Lubiprostone—Headache—Quinine—malaria	0.00176	0.00275	CcSEcCtD
Lubiprostone—Nausea—Dapsone—malaria	0.00176	0.00275	CcSEcCtD
Lubiprostone—Diarrhoea—Quinidine barbiturate—malaria	0.00173	0.00271	CcSEcCtD
Lubiprostone—Diarrhoea—Pentoxifylline—malaria	0.00173	0.00271	CcSEcCtD
Lubiprostone—Nausea—Clindamycin—malaria	0.0017	0.00266	CcSEcCtD
Lubiprostone—Dizziness—Quinidine barbiturate—malaria	0.00168	0.00262	CcSEcCtD
Lubiprostone—Dizziness—Pentoxifylline—malaria	0.00167	0.00262	CcSEcCtD
Lubiprostone—Nausea—Quinidine—malaria	0.00167	0.00261	CcSEcCtD
Lubiprostone—Nausea—Quinine—malaria	0.00167	0.00261	CcSEcCtD
Lubiprostone—Vomiting—Quinidine barbiturate—malaria	0.00161	0.00252	CcSEcCtD
Lubiprostone—Vomiting—Pentoxifylline—malaria	0.00161	0.00252	CcSEcCtD
Lubiprostone—Rash—Quinidine barbiturate—malaria	0.0016	0.0025	CcSEcCtD
Lubiprostone—Dermatitis—Quinidine barbiturate—malaria	0.0016	0.0025	CcSEcCtD
Lubiprostone—Rash—Pentoxifylline—malaria	0.00159	0.0025	CcSEcCtD
Lubiprostone—Dermatitis—Pentoxifylline—malaria	0.00159	0.00249	CcSEcCtD
Lubiprostone—Headache—Quinidine barbiturate—malaria	0.00159	0.00248	CcSEcCtD
Lubiprostone—Headache—Pentoxifylline—malaria	0.00158	0.00248	CcSEcCtD
Lubiprostone—Nausea—Quinidine barbiturate—malaria	0.0015	0.00236	CcSEcCtD
Lubiprostone—Nausea—Pentoxifylline—malaria	0.0015	0.00235	CcSEcCtD
Lubiprostone—CBR1—Arachidonic acid metabolism—HPGDS—malaria	0.00137	0.155	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC4A1—malaria	0.000842	0.0956	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—G6PD—malaria	0.000761	0.0863	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000357	0.0405	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—DHODH—malaria	0.000199	0.0225	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000195	0.0222	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000179	0.0204	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SLC4A1—malaria	0.000169	0.0192	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—DECR1—malaria	0.000159	0.018	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HBB—malaria	0.000144	0.0163	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PKLR—malaria	0.000128	0.0145	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—G6PD—malaria	0.000114	0.013	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CD36—malaria	0.000113	0.0128	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HPGDS—malaria	8.7e-05	0.00988	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—DHFR—malaria	8.07e-05	0.00916	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SCARB1—malaria	7.99e-05	0.00907	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CD36—malaria	5.01e-05	0.00569	CbGpPWpGaD
